Drug Testing: A Practical Guide to Laboratory Panels and Results

Key takeaways

• Drug tests generally begin with an immunoassay screen, and non-negative screens are often confirmed with a more specific method such as mass spectrometry.
• Detection windows vary by drug, specimen type, dose, frequency of use, and individual metabolism, so a negative result does not always rule out recent use.
• Common specimen types include urine, blood, oral fluid, and hair, each with different strengths and limitations.
• Prescription medications, foods, and some over-the-counter products can occasionally cause unexpected screening results, which is one reason confirmatory testing matters.
• Results should be interpreted by a qualified professional in the context of the testing purpose, the specimen used, and the test's cutoff concentrations.

What Drug Testing Measures

Drug testing looks for a parent drug, its metabolites, or both in a specimen. Most drugs are broken down by the body into metabolites, and laboratories often target these metabolites because they remain detectable longer than the original substance. Tests are designed around cutoff concentrations, which are threshold values that determine whether a result is reported as negative or as needing further evaluation.

A drug test is typically ordered for a specific purpose, and that purpose shapes which drugs are included and which specimen is collected. A clinical test may focus on a particular medication or substance related to a patient's care, while a workplace panel may cover a broader set of substances. Because panels are not standardized across all settings, two drug tests can look for different things even when they share a name.

Screening and Confirmation Testing

Screening tests, often immunoassays, are fast and relatively inexpensive and are designed to identify specimens that may contain a drug or metabolite. Immunoassays use antibodies that bind to target compounds, and they can sometimes cross-react with structurally similar substances. As a result, a screening result that is not negative is generally considered presumptive rather than definitive.

When a screening result requires confirmation, laboratories use a more specific technique, commonly gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry. These methods separate and identify compounds by their chemical properties and mass, which greatly reduces the chance of a false positive. A result is usually reported as positive only after it has been confirmed by one of these methods, following established laboratory procedures.

Specimen Types and Detection Windows

Urine is the most common specimen for many drug testing programs because collection is relatively simple and many substances and metabolites are detectable. Blood testing can detect a drug during the period it is present in the bloodstream, which is often shorter than the window for urine. Oral fluid testing reflects recent use and is harder to adulterate, while hair testing can indicate use over a longer retrospective period.

A detection window is the time after use during which a test can reasonably be expected to identify a substance. This window depends on the drug, the dose, how often it was used, the person's metabolism, hydration, and the specimen type. Because of this variability, a negative result does not always mean a person never used a substance, and a positive result does not by itself indicate when or how much was used.

Interpreting Results and Their Limits

A positive result on a confirmed laboratory test indicates that a drug or metabolite was present at or above the test's cutoff. It does not, on its own, establish impairment, dose, frequency of use, or the route of administration. Some substances, including certain prescription medications, can produce expected positive results when a person is using them as prescribed, which is why medical review is often part of a testing program.

Unexpected results can also arise from legitimate sources. Some foods, supplements, and over-the-counter products have been associated with interfering with certain screening assays. Laboratories and medical review officers evaluate these possibilities, and confirmatory testing helps distinguish true positives from cross-reactivity. Anyone with questions about a result should discuss it with the ordering clinician or the laboratory that performed the test.

Frequently Asked Questions

Sources

• MedlinePlus: Drug Testing
• National Institute on Drug Abuse: Drug Testing
• Centers for Disease Control and Prevention: Laboratory Testing
• Mayo Clinic: Drug Testing